Prime Discoveries Biotechnology
2 known investors
Prime Discoveries develops multiplex PCR diagnostic panels that detect pathogens and antimicrobial-resistance genes across areas such as respiratory infection, sepsis, gastrointestinal illness, STIs, tropical fevers, and biosurveillance. Its panels serve clinical diagnostics, hospital infection control, public-health surveillance, pharmaceutical QC, and biodefense applications.
BiotechHealthtechMedical Devices
Investors · 2
Frequently asked questions
- What does Prime Discoveries Biotechnology do?
- Prime Discoveries develops multiplex PCR diagnostic panels that detect pathogens and antimicrobial-resistance genes across areas such as respiratory infection, sepsis, gastrointestinal illness, STIs, tropical fevers, and biosurveillance. Its panels serve clinical diagnostics, hospital infection control, public-health surveillance, pharmaceutical QC, and biodefense applications.
- Who are Prime Discoveries Biotechnology's investors?
- Prime Discoveries Biotechnology's investors include Beresford Ventures, Broad Street Angels.